announced today that it is presenting a Trial in Progress poster for the phase 1 ANCHOR clinical trial at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting being held May 31 ...

Posters will be archived on the Nuvalent website at www.nuvalent.com. The first "Trial in Progress" poster will include background and study design for ALKAZAR (NCT06765109), a global ...

Details for the ASCO Annual Meeting Trials in Progress poster presentation are as follows: Presentation Overview: TITLE: A phase 1 dose-escalation and expansion study of an intratumorally ...

announced today that it is presenting a Trial in Progress poster for the Phase 1 clinical trial evaluating CTIM-76 in ovarian, endometrial, and testicular cancers at the 2025 American Society of ...

Circle Pharma to Present Trials in Progress Poster on CID-078, a First-in-Class Cyclin A/B Inhibitor, at the ASCO 2025 Annual Meeting Circle Pharma, a clinical-stage biopharmaceutical company ...

Poster Presentation Details: Title: “Trials in Progress: A Phase 3 Study to Investigate Efficacy, Safety, and Tolerability of Mavorixafor in Participants with Congenital and Acquired Primary ...

You have permission to edit this article. Edit Close Activate Subscribe My Account Logout Login/Register ...